|
FXN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.837820E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.261600E-03 |
| Normal-vs-Stage2 |
4.174200E-02 |
| Normal-vs-Stage3 |
1.268190E-01 |
| Normal-vs-Stage4 |
7.867800E-01 |
| Stage1-vs-Stage2 |
6.686200E-01 |
| Stage1-vs-Stage3 |
3.352000E-01 |
| Stage1-vs-Stage4 |
2.663400E-01 |
| Stage2-vs-Stage3 |
7.388000E-01 |
| Stage2-vs-Stage4 |
3.436400E-01 |
| Stage3-vs-Stage4 |
4.199600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.397940E-03 |
| Normal-vs-AfricanAmerican |
3.524400E-02 |
| Normal-vs-Asian |
6.511400E-01 |
| Caucasian-vs-AfricanAmerican |
6.014200E-01 |
| Caucasian-vs-Asian |
5.882600E-01 |
| AfricanAmerican-vs-Asian |
7.113400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.402100E-04 |
| Normal-vs-Female |
5.366500E-02 |
| Male-vs-Female |
2.133600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.022600E-01 |
| Normal-vs-Extreme_Weight |
2.302700E-03 |
| Normal-vs-Obese |
4.157900E-02 |
| Normal-vs-Extreme_Obese |
1.097840E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.477400E-01 |
| Normal_Weight-vs-Obese |
6.992000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.745400E-01 |
| Extreme_Weight-vs-Obese |
3.410200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.396200E-01 |
| Obese-vs-Extreme_Obese |
9.338800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.537700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.041500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.098080E-03 |
| Normal-vs-Age(81-100Yrs) |
4.797800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.517600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.836000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.592200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.368200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.095700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.354300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.155400E-03 |
| Normal-VS-Type2 PRCC |
5.427900E-02 |
| Normal-VS-KIRP CIMP |
9.579000E-01 |
| Normal-VS-Unclassified PRCC |
2.098800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.020000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.353420E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.663800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.793800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.832000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.540100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.002400E-03 |
| Normal-vs-N1 |
7.388600E-01 |
| Normal-vs-N2 |
2.123600E-01 |
| N0-vs-N1 |
2.516600E-01 |
| N0-vs-N2 |
9.832400E-01 |
| N1-vs-N2 |
6.313200E-01 |
|
|
